Related Experiment Video
Updated: May 6, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 12, 2013
The Sprint to Develop Coronavirus Antivirals
1Department of Discovery Chemistry, Genentech Inc., South San Francisco, California 94080, United States.
Abstract:
The preclinical work leading to the discovery of PF-07321332 (nirmatrelvir) is described in the Featured Article summarized in this Viewpoint. This work resulted in an Emergency Use Authorization (EUA) for Paxlovid within two years of the project's start. In addition to the medicinal chemistry approach taken, the authors describe how they achieved this remarkable speed.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Single Nucleotide Polymorphisms-SNPs
Pharmacogenomics: Identification of New Drug Targets
Subviral Agents
Inhibitors of Viral Protein Synthesis
Anthelminthic Agents

